Cargando…
Febrile neutropenia in a patient with non-small-cell lung cancer treated with atezolizumab: A case report
Hematological immune-related adverse events (hem-irAEs) related to immunotherapy have not been extensively characterized, and there is no report of neutropenia caused by atezolizumab administration. Herein, we report a case of febrile neutropenia caused by a hem-irAEs due to atezolizumab, which was...
Autores principales: | Seguchi, Kyosuke, Nakashima, Kei, Terao, Toshiki, Takeshita, Gaku, Nagai, Tatsuya, Tanaka, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349032/ https://www.ncbi.nlm.nih.gov/pubmed/34401279 http://dx.doi.org/10.1016/j.rmcr.2021.101439 |
Ejemplares similares
-
Febrile neutropenia in chemotherapy treated small-cell lung cancer patients
por: Kukec, Renata Rezonja, et al.
Publicado: (2015) -
How I Treat Febrile Neutropenia
por: Nucci, Marcio
Publicado: (2021) -
Febrile Neutropenia in a Patient with Non-Small Cell Lung Cancer Treated with the Immune-Checkpoint Inhibitor Nivolumab
por: Hisamatsu, Yasushi, et al.
Publicado: (2020) -
The risk of febrile neutropenia in patients with non-small-cell lung cancer treated with docetaxel: a systematic review and meta-analysis
por: Wailoo, A, et al.
Publicado: (2009) -
Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
por: Naeem, Doaa, et al.
Publicado: (2018)